TFF Pharmaceuticals Investor Relations Material
Latest events
Study Update
TFF Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from TFF Pharmaceuticals Inc
Access all reports
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. The company is developing TFF-Pharma's lead product candidate, TFF-100, a pharmacologically active inhaled dry powder-based fibrosis therapy for the treatment of idiopathic pulmonary fibrosis (IPF) and cystic fibrosis. It owns and has control over the molecule (SMART-Breathe), formulation design, regulatory pathway data from previous phase 1 clinical trials in humans, development milestones and timelines, human safety data from phase 1 clinical trials that can be leveraged for future regulatory activities with health authorities worldwide for the development of the SMART-Breathe formulation for use in the treatment of IPF and CF. The company was founded in 2018 and is headquartered in Austin, Texas.
Key slides for TFF Pharmaceuticals Inc
Study Update
TFF Pharmaceuticals Inc
Study Update
TFF Pharmaceuticals Inc
Latest articles
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Ticker symbol
TFFP
Country
🇺🇸 United States